These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7555038)

  • 1. The effect of age and liver disease on the pharmacokinetics of the calcium antagonist, nisoldipine.
    Davidsson GK; Edwards JS; Davidson C
    Curr Med Res Opin; 1995; 13(5):285-97. PubMed ID: 7555038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertension.
    Bajcetic M; Benndorf RA; Appel D; Schwedhelm E; Schulze F; Riekhof D; Maas R; Böger RH
    J Clin Pharmacol; 2007 Mar; 47(3):295-304. PubMed ID: 17322141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of nisoldipine coat-core.
    Heinig R
    Clin Pharmacokinet; 1998 Sep; 35(3):191-208. PubMed ID: 9784933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form.
    Schaefer HG; Heinig R; Ahr G; Adelmann H; Tetzloff W; Kuhlmann J
    Eur J Clin Pharmacol; 1997; 51(6):473-80. PubMed ID: 9112062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and hemodynamic effects of long-term nisoldipine treatment in hypertensive patients.
    van Harten J; van Brummelen P; Danhof M; Quekel RP; Breimer DD
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):624-9. PubMed ID: 2471001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration.
    van Harten J; van Brummelen P; Wilson JH; Lodewijks MT; Breimer DD
    Eur J Clin Pharmacol; 1988; 34(4):387-94. PubMed ID: 3402524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension.
    Plosker GL; Faulds D
    Drugs; 1996 Aug; 52(2):232-53. PubMed ID: 8841741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of nisoldipine in hypertensive patients with normal and mild to moderate impaired renal function.
    Shionoiri H; Minamisawa K; Masumori S; Satta H; Minamisawa M; Takizawa T; Jinno Y; Takeda K; Nagasawa T; Takasaki I
    Arzneimittelforschung; 1995 Jul; 45(7):785-9. PubMed ID: 8573223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective assay of nisoldipine in human plasma by chiral high-performance liquid chromatography combined with gas chromatographic-mass spectrometry: applications to pharmacokinetics.
    Marques MP; Santos NA; Coelho EB; Bonato PS; Lanchote VL
    J Chromatogr B Biomed Sci Appl; 2001 Oct; 762(1):87-95. PubMed ID: 11589462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
    Langtry HD; Spencer CM
    Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nisoldipine coat-core and heart rate response during treatment of hypertension.
    Zannad F
    Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of once daily versus twice daily nisoldipine as monotherapy in patients over 65 years of age.
    Davidsson GK; Smithard DJ; Edwards JS; Davidson C
    Clin Trials Metaanal; 1994 Oct; 29(2-3):103-11. PubMed ID: 10150222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple dose pharmacokinetics of four different doses of nisoldipine in hypertensive patients.
    Chandler MH; Clifton GD; Lettieri JT; Mazzu AL; Allington DR; Thieneman AC; Foster TS; Harrison MR
    J Clin Pharmacol; 1992 Jun; 32(6):571-5. PubMed ID: 1634646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.
    Pasanisi F; Meredith PA; Reid JL
    Eur J Clin Pharmacol; 1985; 29(1):21-4. PubMed ID: 4054203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What does nisoldipine coat core (CC) add to current therapy that is clinically meaningful?
    Opie LH
    Am J Cardiol; 1997 May; 79(10A):29-32; discussion 47-8. PubMed ID: 9186064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of grapefruit pulp on the pharmacokinetics of the dihydropyridine calcium antagonists nifedipine and nisoldipine].
    Ohtani M; Kawabata S; Kariya S; Uchino K; Itou K; Kotaki H; Kasuyama K; Morikawa A; Seo I; Nishida N
    Yakugaku Zasshi; 2002 May; 122(5):323-9. PubMed ID: 12040751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of nisoldipine in renal dysfunction.
    Boelaert J; Valcke Y; Dammekens H; De Vriese G; Ahr G; Schurgers M; Daneels R; Bogaert MG
    Eur J Clin Pharmacol; 1988; 34(2):207-9. PubMed ID: 3383992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine.
    van Harten J; van Brummelen P; Lodewijks MT; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1988 Mar; 43(3):332-41. PubMed ID: 3345623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.